Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
With compounded semaglutide injections starting at $199/month, ShedRx keeps GLP-1 therapy within reach for many under-insured patients
The effectiveness of OZEMPIC tablets (1.5 mg, 4 mg and 9 mg strengths) [see Dosage and Administration (2.2)] and RYBELSUS (3 mg, 7, mg and 14 mg strengths) [see Dosage and Administration (2.3)] has been established as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus based on adequate and well-controlled studies of RYBELSUS in adult patients with type 2 diabetes mellitus [see Clinical Pharmacology (12.3)]
Genetic variants in the GLP1-related genes are linked to obesity and diabetes
Longer treatment durations up to several months have been examined in chronic disease models without apparent tolerance development or diminishing efficacy
History Tirzepatide is a 39-amino acid synthetic peptide developed by Eli Lilly and Company
Originally developed for diabetes care, it has now gained widespread attention for its role in helping people achieve sustainable weight loss
